444

JCR PHARMACEUTICAL CO

No trades
See on Supercharts
Market capitalization
‪99.12 B‬JPY
‪3.77 B‬JPY
‪34.34 B‬JPY
‪65.57 M‬
Beta (1Y)
1.52

About JCR PHARMACEUTICAL CO

CEO
Shin Ashida
Headquarters
Ashiya
Employees (FY)
879
Founded
1975
ISIN
JP3701000006
FIGI
BBG000BBW881
JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following segments: Pharmaceutical Business; and Medical and Research Equipment Business. The Pharmaceutical Business segment deals with the manufacture, purchase, and sale of ethical drugs, active pharmaceutical ingredients, and raw materials. The Medical and Research Equipment Business segment sells medical devices and laboratory equipment. The company was founded by Shin Ashida on September 13, 1975 and is headquartered in Ashiya, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 4552 is 781 JPY — it has decreased by 2.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange JCR PHARMACEUTICAL CO stocks are traded under the ticker 4552.
JCR PHARMACEUTICAL CO is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
4552 stock is 2.83% volatile and has beta coefficient of 1.52. Check out the list of the most volatile stocks — is JCR PHARMACEUTICAL CO there?
One year price forecast for JCR PHARMACEUTICAL CO has a max estimate of 2700 JPY and a min estimate of 1200 JPY.
4552 earnings for the last quarter are 29.19 JPY per share, whereas the estimation was 12.95 JPY resulting in a 125.42% surprise. The estimated earnings for the next quarter are 3.53 JPY per share. See more details about JCR PHARMACEUTICAL CO earnings.
JCR PHARMACEUTICAL CO revenue for the last quarter amounts to ‪13.46 B‬ JPY despite the estimated figure of ‪10.15 B‬ JPY. In the next quarter revenue is expected to reach ‪8.24 B‬ JPY.
Yes, you can track JCR PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
4552 stock has fallen by 5.33% compared to the previous week, the month change is a 10.84% fall, over the last year JCR PHARMACEUTICAL CO has showed a 47.30% decrease.
4552 net income for the last quarter is ‪−92.00 M‬ JPY, while the quarter before that showed ‪3.64 B‬ JPY of net income which accounts for −102.52% change. Track more JCR PHARMACEUTICAL CO financial stats to get the full picture.
Today JCR PHARMACEUTICAL CO has the market capitalization of ‪99.72 B‬, it has increased by 1.00% over the last week.
JCR PHARMACEUTICAL CO dividend yield was 1.42% in 2022, and payout ratio reached 65.91%. The year before the numbers were 0.97% and 18.76% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4552 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JCR PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
4552 reached its all-time high on Jan 29, 2021 with the price of 3800 JPY, and its all-time low was 157 JPY and was reached on Dec 16, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 879.00 employees. See our rating of the largest employees — is JCR PHARMACEUTICAL CO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JCR PHARMACEUTICAL CO technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JCR PHARMACEUTICAL CO stock shows the sell signal. See more of JCR PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on JCR PHARMACEUTICAL CO future price: according to them, 4552 price has a max estimate of 2700.00 JPY and a min estimate of 1200.00 JPY. Read a more detailed JCR PHARMACEUTICAL CO forecast: see what analysts think of JCR PHARMACEUTICAL CO and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JCR PHARMACEUTICAL CO EBITDA is ‪10.65 B‬ JPY, and current EBITDA margin is 20.31%. See more stats in JCR PHARMACEUTICAL CO financial statements.